Behavioral disinhibition with baclofen

Journal of Clinical Psychopharmacology

Volumn 30, Issue 6, 2010, Pages 759-760

  Soufia, Michel ^a   Plaze, Marion ^a   Gueguen, Bernard ^a   Demigneux, Gilles ^a   Olié, Jean Pierre ^a   Gaillard, Raphael ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; DIAZEPAM; DISULFIRAM;

AGED; AGGRESSIVENESS; ALCOHOL ABSTINENCE; ALCOHOL BLOOD LEVEL; ALCOHOLISM; BEHAVIOR DISORDER; BEHAVIORAL DISINHIBITION; CASE REPORT; DRUG DOSE INCREASE; ELECTROENCEPHALOGRAPHY; HUMAN; IRRITABILITY; LETTER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; RESTLESSNESS;

AGED; ALCOHOLISM; BACLOFEN; BEHAVIORAL SYMPTOMS; GABA-B RECEPTOR AGONISTS; HUMANS; INHIBITION (PSYCHOLOGY); MALE;

EID: 78649347023     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181fb7b97     Document Type: Letter

References (15)

1. Ameisen O. Treatment of alcohol-use disorders. Lancet. 2009;373:1519; author reply 1519-1520.
2. Malcolm RJ. GABA systems, benzodiazepines, and substance dependence. J Clin Psychiatry. 2003;64(suppl 3):36-40.
3. Maccioni P, Bienkowski P, Carai MA, et al. Baclofen attenuates cue-induced reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend. 2008;95:284-287.
4. Garbutt JC, Kampov-Polevoy AB, Gallop R, et al. Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcohol Clin Exp Res. 2010;[Epub ahead of print].
5. Johnson BA. Medication treatment of different types of alcoholism. Am J Psychiatry. 2010;167(6):630-639.
6. Ameisen O. Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician. Alcohol Alcohol. 2005;40:147-150.
7. Kandemir H, Yumru M, Kul M, et al. Behavioral disinhibition, suicidal ideation, and self-mutilation related to clonazepam. J Child Adolesc Psychopharmacol. 2008;18:409.
8. Gaillard R, Hemras A, Habert MO, et al. Cognitive facilitation and behavioral disinhibition with benzodiazepine: a case report. J Clin Psychiatry. 2007;68: 1305-1306.
9. Northoff G. What catatonia can tell us about Btop-down modulation[: a neuropsychiatric hypothesis. Behav Brain Sci. 2002;25: 555-577; discussion 578-604.
10. Cohen L, Chaaban B, Habert MO. Transient improvement of aphasia with zolpidem. N Engl J Med. 2004;350(9):949-950.
11. Thomas P, Rascle C, Mastain B, et al. Test for catatonia with zolpidem. Lancet. 1997; 349(9053):702.
12. Northoff G, Kötter R, Baumgart F, et al. Orbitofrontal cortical dysfunction in akinetic catatonia: a functional magnetic resonance imaging study during negative emotional stimulation. Schizophr Bull. 2004;30(2): 405-427.
13. Richter A, Grimm S, Northoff G. Lorazepam modulates orbitofrontal signal changes during emotional processing catatonia. Hum Psychopharmacol. 2010;25(1):55-62.
14. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245.
15. Hormes JT, Benarroch EE, Rodriguez M, et al. Periodic sharp waves in baclofen-induced encephalopathy. Arch Neurol. 1988;45: 814-815.